BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price reached a new 52-week high during trading on Tuesday . The stock traded as high as $1.52 and last traded at $1.47, with a volume of 130716 shares changing hands. The stock had previously closed at $1.48.
BioRestorative Therapies Trading Down 0.7 %
The firm has a fifty day moving average of $1.35 and a 200 day moving average of $1.62. The company has a market capitalization of $2.41 billion, a P/E ratio of -1.38 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Recommended Stories
- Five stocks we like better than BioRestorative Therapies
- Transportation Stocks Investing
- Garmin Navigates to New Highs Driven By Wearables Trend
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- What to Know About Investing in Penny Stocks
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.